The missing middle of sickle therapeutics: Multi-agent therapy, targeting risk, using biomarkers

Robert P. Hebbel, Jacques Elion, Abdullah Kutlar

Research output: Contribution to journalComment/debate

Original languageEnglish (US)
Pages (from-to)1439-1443
Number of pages5
JournalAmerican Journal of Hematology
Volume93
Issue number12
DOIs
StatePublished - Dec 2018

Fingerprint

Biomarkers
Therapeutics

ASJC Scopus subject areas

  • Hematology

Cite this

The missing middle of sickle therapeutics : Multi-agent therapy, targeting risk, using biomarkers. / Hebbel, Robert P.; Elion, Jacques; Kutlar, Abdullah.

In: American Journal of Hematology, Vol. 93, No. 12, 12.2018, p. 1439-1443.

Research output: Contribution to journalComment/debate

@article{54e5adca5a67445f85e375845083edac,
title = "The missing middle of sickle therapeutics: Multi-agent therapy, targeting risk, using biomarkers",
author = "Hebbel, {Robert P.} and Jacques Elion and Abdullah Kutlar",
year = "2018",
month = "12",
doi = "10.1002/ajh.25289",
language = "English (US)",
volume = "93",
pages = "1439--1443",
journal = "American Journal of Hematology",
issn = "0361-8609",
publisher = "Wiley-Liss Inc.",
number = "12",

}

TY - JOUR

T1 - The missing middle of sickle therapeutics

T2 - Multi-agent therapy, targeting risk, using biomarkers

AU - Hebbel, Robert P.

AU - Elion, Jacques

AU - Kutlar, Abdullah

PY - 2018/12

Y1 - 2018/12

UR - http://www.scopus.com/inward/record.url?scp=85055515439&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85055515439&partnerID=8YFLogxK

U2 - 10.1002/ajh.25289

DO - 10.1002/ajh.25289

M3 - Comment/debate

C2 - 30230577

AN - SCOPUS:85055515439

VL - 93

SP - 1439

EP - 1443

JO - American Journal of Hematology

JF - American Journal of Hematology

SN - 0361-8609

IS - 12

ER -